Company: CERO
Filing Date: 2025-07-21
Form Type: S-1
Source: 0001213900-25-066152
Chunk: 34

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-07-21
Form: S-1
Chunk 34
---
 the Common Stock or result in a significant decline in the public trading price of the Common Stock. 11 Sales of a substantial number of our securities in the public market by the Selling Securityholder and/or by our existing securityholders could cause the price of our Common Stock and Warrants to fall. The securities being offered in this prospectus represent a substantial percentage of our outstanding shares of Common Stock and Warrants. Under this prospectus, the Selling Securityholder can resell up to total of 12,500,000 shares of Common Stock. Sales of a substantial number of shares of our Common Stock in the public market, including the resale of the shares held by the Selling Securityholder, could occur at any time (after the expiration of any applicable lock-up period, assuming the satisfaction of any applicable vesting conditions and subject to the beneficial ownership and stock exchange limitations described herein). These sales, or the perception in the market that the holders of a large number of shares of our Common Stock intend to sell shares, could increase the volatility of the market price of our Common Stock or result in a significant decline in the public trading price of our Common Stock. The shares of Common Stock being offered for resale pursuant to this prospectus by the Selling Securityholder represent approximately 85.5% of shares of fully-diluted Common Stock outstanding as of June 30, 2025, assuming and after giving effect to the conversion of all outstanding Preferred Shares, the exercise of all outstanding Warrants and options, and options available for issuance pursuant to our 2024 Plan and 2024 ESPP Plan, as amended from time to time, of which 1,994,227 shares were held by non-affiliates (without taking into account beneficial ownership or stock exchange limitations). After the registration statement of which this prospectus forms a part is effective and until such time that it is no longer effective, it will permit the resale of these shares of Common Stock. The resale, or expected or potential resale, of a substantial number of shares of our Common Stock in the public market could adversely affect the market price for our Common Stock and make it more difficult for you to sell your holdings at times and prices that you determine are appropriate. Furthermore, we expect that, because there is a large number of shares of our Common Stock being registered pursuant to the registration statement of which this prospectus forms a part, the Selling Securityholder thereunder will continue to offer the securities covered thereby for a significant period of time, the precise duration of which cannot be predicted. Accordingly